SCHEMBL5223878

SCHEMBL5223878

CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(c3)nc(NC(=O)Cc3ccc(Cl)c(Cl)c3)n4C)n2)c1

nearest known ligand 0.54

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
KDR P35968 11/20 0.41
CYP3A4 P08684 2/20 0.41
CYP2D6 P10635 2/20 0.41
CYP2C9 P11712 2/20 0.41
CYP2C19 P33261 2/20 0.41
RORC P51449 1/20 0.39
PARP1 P09874 2/20 0.38
ALK Q9UM73 3/20 0.38
PKM P14618 1/20 0.35
FLT1 P17948 2/20 0.35
FLT4 P35916 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
RXFP1 Q9HBX9 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5226070 0.89 KDR (0.39) KDRCYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL4979215 0.87 ALK (0.38) KDRRORCPARP1ALKFLT1
SCHEMBL5226379 0.86 KDR (0.41) KDRCYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL5225921 0.82 KDR (0.55) KDRCYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL5226814 0.81 KDR (0.39) KDRCYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL5225600 0.80 KDR (0.62) KDRCYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL5223137 0.80 KDR (0.56) KDRCYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL4978445 0.79 KDR (0.54) KDRCYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL4978452 0.77 PKM (0.43) KDRCYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL4979212 0.77 ROCK2 (0.43) KDRRORCALKFLT1FLT4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7338959-B2 Diamino-pyrimidines and their use as angiogenesis inhibitors SMITHKLINE BEECHAM CORPORATION (US) 2008-03-04 US disclosed
US-7338959-B2 Diamino-pyrimidines and their use as angiogenesis inhibitors SMITHKLINE BEECHAM CORPORATION (US) 2008-03-04 US disclosed
EP-1487824-B1 DIAMINO-PYRIMIDINES AND THEIR USE AS ANGIOGENESIS INHIBITORS SMITHKLINE BEECHAM CORP (US) 2007-06-20 EP disclosed
EP-1487824-B1 DIAMINO-PYRIMIDINES AND THEIR USE AS ANGIOGENESIS INHIBITORS SMITHKLINE BEECHAM CORP (US) 2007-06-20 EP disclosed